Table 1.

Summary of anti-HIV triterpenoids and their targets and activities.

Compounds	IC50	EC50	Targets	References
1	-	-	Entry inhibitors	[16]
8	57.7 μM 30.3 μM	-	Protease inhibitors Integrase inhibitors	[46] [45]
10	8 μM	-	Protease inhibitors	[28]
	35 μM	-	Integrase inhibitors	[45]
11	13 μM	-	Protease inhibitors	[28]
13	-	-	Protease inhibitors	[30]
16	24.8 μM	-	Integrase inhibitors	[45]
17	17.7 μM	-	Integrase inhibitors	[45]
18	11.6 μM	-	Reverse transcriptase inhibitor	[36]
19	0.03 μM	-	Maturation inhibitors	[44]
20	0.02 μM	-	-	[44]
21	4.08 μM	-	Replication inhibition	[52]
22	4.18 μM	-	Replication inhibitors	[52]
23	1.70 μM	-	Replication inhibitors	[52]
34	>1.0 mM	-	Protease inhibitors	[47]
35	7.8 μg/mL	-	Protease inhibitors	[48]
40	30 μM	-	Protease inhibitors	[48]
41	48 μM	-	Protease inhibitors	[48]
42	25 μM	-	Protease inhibitors	[48]
43	-	20.69 μg/mL	-	[32]
44	-	16.6 μg/mL	-	[32]
45	-	16.2 μg/mL	-	[32]
46	-	10.3 μg/mL	-	[32]
	15.79 μM	-	Protease inhibitors	[35]
47	20.44 μM	-	Protease inhibitors	[35]
48	-	6.1 μg/mL	-	[33]
50	-	1.4 μg/mL	-	[34]
53	-	1.24 μM	-	[53]
54	-	-	-	[54]